Summary
Cyclophosphamide (Endoxan®) is a cytostatic with antineoplastic and immunosuppressant activity that has been used in dermatology for over 30 years. Its use is essentially limited to serious or life-threatening autoimmune and/or systemic diseases because of its haematological toxicity and the risk of drug-induced neoplasia following prolonged use.
×
N.B. : This limited content is for the general public. If you are a health professional, click here to register for free and gain access to a dedicated deeper content.
If you already have an account, log in!
Therapeutics in Dermatology, Fondation René Touraine © 2001-2012
